Gaurav Chandra
Gaurav Chandra
Contributor, The Yuan

Gaurav Chandra is the chief operating officer of drug developer Enzolytics. He also runs a platform that uses AI to assess the effects of nutrition, genetics and gut microbiome on chronic medical diseases and infectious diseases. He is a strong proponent of AI's role in early drug discovery and development.

Bot vs. bug: AI’s role in the global antimicrobial resistance crisis
Optimization
Dr Gaurav Chandra discusses AI's role in antimicrobial resistance from diagnosis to therapy, asserting that humanity limits its scientific potential by not embracing the concept of information-sharing for the greater good, and concluding that moving away from working in silos, data-sharing, and creating more extensive databases can assist in early diagnosis and development of novel therapeutics for AMR.
Gaurav Chandra  |  Sep 07, 2022
War of the machines: AI develops sepsis early warning systems
New era
After the development of antiseptics, antibiotics, and antibacterial drugs, humanity has had to contend with drug-resistant ‘super bacteria.’ This, problem and the ongoing one of sepsis - with its high risk of death if left untreated - remains unsolved, but if AI, Big Data, and ML are properly applied, they may finally achieve victory in this centuries-long fight.
Gaurav Chandra  |  Aug 30, 2022
Open data: Holy Grail or Pandora’s box?
Open Data 2022
Dr Gaurav Chandra discusses the importance of making medical data accessible to all, connecting global medical data with precision medicine, and calling awareness to the necessity for different governments to open up their medical data to promote the progress of digital health. The conclusion is that the value of artificial intelligence to healthcare lies in better collaboration, innovation, the inclusion of all stakeholders in decision making, and integrity in data custodianship.
Gaurav Chandra  |  Jun 23, 2022
AI-Driven Diagnostics Transform Healthcare
Optimization
In the pandemic’s wake, the world still faces massive challenges in detecting and diagnosing many life-threatening illnesses. Dr Gaurav Chandra explores the evolution of healthcare from reactivity to prevention, prediction, participation, and personalization, along with the part that artificial intelligence-driven diagnostics has played in this transformation.
Gaurav Chandra  |  Apr 04, 2022
The Yuan AI 2022 - To Infinity and Beyond
New era
Dr Gaurav Chandra presents the second in a series of articles this week on The Yuan platform predicting the evolution of artificial intelligence in 2022. He looks forward to what the future holds for us next year and explores five trends in AI that will shape humankind forever.
Gaurav Chandra  |  Dec 28, 2021
AI Provides Key to Pandemic Preparedness
Pandemic
The world appears to be on the cusp of monumental transformation in healthcare, thanks in no small part to COVID-19 which has provided a platform for the Fourth Industrial Revolution. Dr Gaurav Chandra believes this is an ideal opportunity for humanity to come together, work on tangible solutions to free us of this pandemic, prevent another, and leave a legacy for future generations.
Gaurav Chandra  |  Dec 20, 2021
Demystifying the Human Microbiome Using AI
Optimization
Artificial Intelligence continues to be a significant driver for advancing healthcare and understanding the microbiome will be pivotal to that transformation. Dr Gaurav Chandra discusses the crucial role the microbiome will play, enabling precision medicine that is more preventive, predictive, and personal than ever before.
Gaurav Chandra  |  Dec 01, 2021